Dr. Stanley Zaslau, MD

Dr. Zaslau practices at Rockefeller Neuroscience Institute - Neurology - HOPD in Morgantown, West Virginia.

Dr. Zaslau's NPI, 1821183278, was assigned on October 3, 2006. Dr. Zaslau graduated from Hahneman Medical College of the Pacific in 1994. Dr. Zaslau holds West Virginia license 20703.

Dr. Zaslau's primary practice is Rockefeller Neuroscience Institute - Neurology - HOPD, at 33 Medical Center Dr, Morgantown, WV 26505.

Dr. Zaslau's primary practice is Rockefeller Neuroscience Institute - Neurology - HOPD in Morgantown, West Virginia. Dr. Zaslau is also affiliated with Reynolds Memorial Hospital. The medical group on file is University Health Associates. Dmand AI also links Dr. Zaslau to 5 more hospitals and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Zaslau practices, 7 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Zaslau's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Zaslau is licensed in West Virginia.

CMS data shows 357 Medicare services from Dr. Zaslau across 11 procedure codes in 2024, for 314 Medicare patients. Medicare paid $21,517 for them.

CMS counts 314 Medicare patients who saw Dr. Zaslau in 2024. The largest group is 65 to 74, with 109 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 17% are also on Medicaid. Their average risk score is 1.98, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Zaslau's median patient age at 67, with 40% women.

In 2024, Dr. Zaslau wrote 1,113 Medicare Part D claims for 211 patients. 88% of them were for generic drugs. CMS names the drug for 1,003 of them, across 25 drugs with 11 or more claims each, at $119,423 in total drug cost. In 2023, CMS named 866 claims across 23 drugs.

Dr. Zaslau accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Zaslau as offering telehealth.

Prostate resection: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 41 papers to Dr. Zaslau, published from 2012 to 2024. 2023 was the busiest year, with 6. The most frequent topics are Crohn Disease, Electric Stimulation Therapy and Prostatic Neoplasms. Dr. Zaslau has published most often in Can J Urol. Dr. Zaslau's most frequent co-authors are Chad Edwin Morley, MD, Robert David Jansen, MD and Stanley J. Kandzari, MD.

CMS Open Payments shows 190 general payments to Dr. Zaslau from 12 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 51% of the total. Medtronic, Inc. paid the most, $11,973.

Dr. Zaslau graduated from Hahneman Medical College of the Pacific in 1994.